In a very recent analyze, we documented the identification and also the characterization of a completely new atypical opioid receptor with exclusive detrimental regulatory properties in direction of opioid peptides.1 Our final results showed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can https://johnathanmuqlt.tribunablog.com/conolidine-an-overview-43784899